Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Puricase in Refractory Gout
NCT00080210Phase 2Completed
- Sponsor
- Savient Pharmaceuticals
- Start
- Mar 2004
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegloticase in gout, sponsored by Savient Pharmaceuticals. Started Mar 2004; status: completed.
02
Drugs
pegloticase
03
Conditions
gout
Beyond the preview
Go deeper on NCT00080210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080210.